Viewing nowRatoBA Tablet (Atorvastatin Calcium Trihydrate)
Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Aprogen BioLogic, Co., Ltd.

MFDS item code 200802335 · Approved 2008.02.29 · Insurance code 645203870
Improvement of hyperlipidemia; prevention of cardiovascular diseases (myocardial infarction, stroke, etc.)
This medication helps reduce the risk of cardiovascular diseases, particularly in high-risk adults and patients with type 2 diabetes by decreasing the risk of myocardial infarction, stroke, complications following vascular interventions, and angina. It also lowers the risks associated with myocardial infarction, stroke, congestive heart failure hospitalizations, and angina in patients with existing heart conditions. In patients with hyperlipidemia, it lowers levels of total cholesterol, LDL cholesterol, Apo-B proteins, and triglycerides while increasing HDL cholesterol levels. It is especially effective as an adjunct to diet in patients with familial hypercholesterolemia and high-risk pediatric patients. This drug is used for the prevention of cardiovascular diseases and the improvement of hyperlipidemia.
Patients receiving atorvastatin should follow a standard cholesterol-lowering diet before and during treatment. The medication may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily; however, for patients requiring a greater reduction in LDL cholesterol, treatment may be initiated at 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This medication is administered once daily at doses ranging from 10 ~ 80 mg. The initial and maintenance doses of this medication should be individualized according to patient characteristics, taking into consideration treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after treatment initiation and/or dose titration, and the dose should be adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, it is recommended that LDL cholesterol be used at the start of treatment and when assessing response to treatment. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor response to treatment. Patients with homozygous familial hypercholesterolemia This medication is administered at a dose of 10 ~ 80 mg once daily, in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are not available. ○ Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. ○ Older adults: The efficacy and safety in patients aged 70 years or older are similar to those in the general adult patient population.
Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose is 10 mg of this medication once daily, and the recommended maximum dose is 20 mg once daily (there are no clinical data on doses of this medication higher than 20 mg in pediatric patients). The dose should be adjusted as appropriate in each patient according to the recommended treatment goals. The dose should be adjusted at intervals of 4 weeks or longer.
This medication should be discontinued immediately and a doctor consulted if any muscle symptoms occur. Caution is particularly necessary if there is severe muscle pain or weakness or a significant increase in creatine kinase levels. This medication should not be administered to patients with certain conditions or those taking specific medications, nor should it be used by women who are pregnant or breastfeeding, or children under 10 years of age. Patients with liver or kidney dysfunction, alcoholics, and the elderly should use this medication with greater caution, and regular monitoring of liver function and muscle condition is important. This medication can cause various side effects such as liver dysfunction, hepatitis, skin rash, and allergic reactions, so symptoms should be reported to healthcare professionals immediately. Interactions can occur when this medication is taken with others, so all medications being taken should be disclosed to healthcare providers, especially when combined with certain antibiotics, antifungals, antivirals, colchicine, and nicotinic acid. This medication should not be taken during pregnancy, and women of childbearing potential should ensure effective contraception while taking it. It should also be avoided during breastfeeding. There is no specific antidote for overdose, so appropriate treatment must be provided based on symptoms, and monitoring of liver function and muscle condition is required. Keep this medication out of the reach of children and store it in its original container.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a tightly closed container. The storage temperature should be maintained between 1°C and 30°C at room temperature. This will help keep the medication's effectiveness safe for an extended period.
White round film-coated tablets
30, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Aprogen BioLogic, Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.